Eric Topol, a cardiologist and leading longevity expert, told Business Insider after looking at Eli Lilly's clinical trial results
As indications continue to grow, the review emphasizes that nurse practitioners (NPs) must balance enthusiasm with vigilance
Certain conditions, such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, may mean that GLP-1 medications are not recommended
This article highlights the importance of knowing your specific Kaiser Permanente plan details and the evolving criteria that could affect coverage, especially with upcoming changes set for January 1, 2025
Overall, the primary composite endpoint occurred in 331 patients of 1767 (18.7%) on Ozempic (1 mg) and 410 patients of 1766 (23.2%) on placebo (HR, 0.76 [95% CI: 0.66-0.88] P =0.0001 for superiority)